CINC424A2X01B

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CINC424A2X01B, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: CINC424A2X01B Rollover Protocol [Phase 4]